Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

102.16
-0.1100-0.11%
Post-market: 102.00-0.1600-0.16%19:30 EDT
Volume:1.37M
Turnover:139.66M
Market Cap:4.20B
PE:-99.35
High:102.35
Open:102.06
Low:101.31
Close:102.27
52wk High:107.69
52wk Low:85.36
Shares:41.10M
Float Shares:41.10M
Volume Ratio:10.89
T/O Rate:3.32%
Dividend:1.44
Dividend Rate:1.41%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.08
PE(LYR):-99.35

Loading ...

HeraMED Secures Full-Scale Digital Maternity Rollout with US Health System Lee Health

TIPRANKS
·
5 hours ago

Irish Central Bank Raises Growth Forecasts on AI Investment Boom

Reuters
·
6 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
8 hours ago

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
9 hours ago

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
10 hours ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
12 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
12 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Yesterday

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Yesterday

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

Covista to invest $150,000 in The Health Collaborative

TIPRANKS
·
Yesterday

Gix Makes Strategic Investment in Ottonomy, a Physical AI, L4 Autonomy and Robotics Technology Company

GlobeNewswire
·
Yesterday